Tethys BioScience Company
Tethys BioScience, Inc. engages in the discovery, development, and commercialization of biological markers. Its products are used to diagnosis the metabolic diseases, such as diabetes. The company offers PreDx Diabetes Risk Test, a diagnostic test that analyzes a set of multiple proteins and other blood borne biomarkers implicated in the development of diabetes. Tethys BioScience, Inc. was founded in 2002 and is based in Emeryville, California.
Industry:
Biomarkers for Longevity
Headquarters:
Emeryville, California, United States
Zip:
51-100
Founded Date:
2002-01-01
Employees Number:
51-100
Acquisitions Number:
10
Investors Number:
75400000
Total Funding:
75400000
Last Funding Date:
Debt Financing
Last Funding Type:
info@tethysbio.com
Register and Claim Ownership